Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system

Details for Australian Patent Application No. 2005335652 (hide)

Owner Indivumed GmbH

Inventors Juhl, Hartmut; David, Kerstin; Fentz, Anne-Kristin

Agent Fisher Adams Kelly

Pub. Number AU-A-2005335652

PCT Pub. Number WO2007/019875

Filing date 19 August 2005

Wipo publication date 22 February 2007

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/019875 Priority application(s): WO2007/019875

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005335653-Device and method for assisting heat ablation treatment of the heart

2005335643-The ocean wave energy converter (OWEC)